Please enable JavaScript in your browser's preferences to use all of the features available on this site.
NeuroTherapeutics Pharma Closes $43 million Series B Financing and Adds Four New Investors
NTP Receives Investment from the Epilepsy Therapy Project
NTP Appoints Dr. Corey Goodman to its Board of Directors